Beyeonics Surgical Notes Dr. Sharon Bakalash Appointed CMO Effective October 1, 2020

December 22, 2020

Beyeonics Surgical announced Dr. Sharon Bakalash was appointed chief medical officer effective October 1, 2020.

Beyeonics Surgical notes Dr. Sharon Bakalsh is a seasoned biotechnology entrepreneur and an ophthalmic surgeon with more than two decades of demonstrated leadership in business, science, and medicine. Before stepping in as Beyeonics Surgical CMO, she had worked with the company as a consultant for nearly 4 years.

As the founder of SB Strategic Development Consultants Group, she provided clinical development, strategic planning, and business development guidance to Beyeonics, as well as with other start-up companies, venture funds and global pharma companies- spanning the pharmaceutical, drug delivery and surgical device arenas.

Dr. Bakalash had served in various roles of exceeding responsibilities within the pharmaceutical industry.  In her last role within Novartis, she was responsible for the US early development portfolio in both Ophthalmology and ENT—forming development strategies, enabling pipeline enrichment stemming for both external and internal innovation.  Prior to that, she headed business development at Alcon, where she was evaluated, negotiated, and oversaw numerous transactions- spanning acquisitions, joint ventures, and a wide variety of co- development frameworks.

Prior to Novartis, Dr. Bakalash was a part of the Harvard University Office of Technology Development, out-licensing innovations stemming from the medical school.

Dr. Bakalash holds an MD from Ben Gurion University, a PhD in Neuroimmunology from the Weizmann Institute of Science, and a business degree from Northeastern University. Dr. Bakalash has also completed a post-doctoral fellowship at Harvard University.

Other Executives In the News

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Executives on the Move

Dr A Burton Tripathi brings over two decades of Medical Device leadership experience, specializing in developing disruptive technologies, leading commercialization efforts, and facilitating M&A. Having recently served as CEO of TrueVision Systems Inc., he concluded the sale and integration of TrueVision with Alcon.
John Taylor brings more than 30 years of regulatory experience to his role at ELIQUENT, including a distinguished 20-year career at the U.S. Food and Drug Administration (FDA), where he served in multiple leadership positions, including as FDA’s Acting Deputy Principal Commissioner, FDA Counselor to the Commissioner, Acting Deputy Commissioner for Global Regulatory Operations and Policy, and Associate Commissioner for Regulatory Affairs.
Jennifer Riter comes to Kindeva from West Pharmaceutical where she spent the past 27 years in various technical and leadership roles, most recently serving as the Senior Director, Business and Technical Operations.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version